Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
IVV ETF Rises 1.6%

IVV ETF Rises 1.6%

Dow JonesDow Jones2026/11/04 21:36

This article was automatically generated using Dow Jones technology.

Shares of iShares Core S&P 500 ETF advanced 1.6% to $770.17 Wednesday on what proved to be an overall favorable trading session for the U.S. stock market, with the S&P 500 Index, the fund's underlying index, rising 1.6% to 7,688.62.

This was the fund's second consecutive day of gains.

The ETF's shares closed 1.9% below the 52-week high of $785.03 seen on October 6, 2026.

Trading volume was 5,221,022, compared to the 65-day average trading volume of 6,407,226.

As of November 3, the fund's net asset value totaled $757.87 per share.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 04, 2026 16:36 ET (21:36 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss